A client with Parkinson's disease who is taking carbidopa/levodopa reports that urine appears to be darker in color. Which action should the nurse take?
Encourage an increase in oral intake.
Measure the client's urinary output.
Explain that color change is normal.
Obtain a specimen for a urine culture.
The Correct Answer is C
Choice A reason: Encouraging an increase in oral intake is not necessary in this situation, as dark urine is not a sign of dehydration or fluid imbalance. Dark urine may be caused by certain foods, medications, or medical conditions, but it does not indicate a need for more fluids.
Choice B reason: Measuring the client's urinary output is not relevant to this situation, as dark urine is not a sign of urinary retention or obstruction. Urinary output may vary depending on fluid intake, activity level, or other factors, but it does not reflect urine color.
Choice C reason: Explaining that color change is normal is the appropriate action to take, as dark urine is a common and harmless side effect of carbidopa/levodopa, which is a combination drug used to treat Parkinson's disease by increasing dopamine levels in the brain. Carbidopa/levodopa can cause urine to turn brown, black, or red, but this does not affect the function or health of the kidneys or bladder.
Choice D reason: Obtaining a specimen for a urine culture is not necessary in this situation, as dark urine is not a sign of infection or inflammation. A urine culture may be indicated if the client has symptoms such as fever, pain, burning, frequency, or urgency, but it does not diagnose urine color
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A reason: Notifying the healthcare provider of the carbamazepine level is not necessary, as 8.4 mg/L (35.6 mcmol/L) is within
the normal range of 4 to 12 mg/L (16.9 to 50.8 mcmol/L). The healthcare provider may adjust
the dose based on other factors such as clinical response, seizure frequency, or adverse effects,
but not based on this level alone.
Choice B reason: Administering the carbamazepine as prescribed is the appropriate action to take, as 8.4 mg/L (35.6 mcmol/L) is within
the normal range of 4 to 12 mg/L (16.9 to 50.8 mcmol/L). The nurse should follow the prescribed
dose and schedule of carbamazepine to maintain a therapeutic level and prevent seizures.
Choice C reason: Assessing the client for side effects of carbamazepine is important, as carbamazepine can cause adverse effects such as drowsiness, dizziness, nausea, rash, or blood dyscrasias. However, this action is not related to the carbamazepine level, as side effects can occur at any level and may not correlate with the serum concentration. The nurse should monitor the client for side effects regardless of the carbamazepine level.
Choice D reason: Withholding this dose of carbamazepine is not appropriate, as 8.4 mg/L (35.6 mcmol/L) is withinthe normal range of 4 to 12 mg/L (16.9 to 50.8 mcmol/L). Withholding the dose may cause a drop in the serum concentration and increase the risk of seizures. The nurse should administer the carbamazepine as prescribed unless instructed otherwise by the healthcare provider.
Correct Answer is C
Explanation
Choice A reason: Nausea and diarrhea are possible side effects of ginkgo biloba, but they are not as serious or common as the risk of bleeding caused by the interaction with aspirin and non-steroidal anti-inflammatory drugs. Therefore, this information is not as important as choice c.
Choice B reason: Anxiety and headaches are not associated with the use of ginkgo biloba, but rather with the underlying condition of multiple sclerosis. Therefore, this information is not relevant or accurate for this client.
Choice C reason: Aspirin and non-steroidal anti-inflammatory drugs interact with ginkgo biloba, as both substances have antiplatelet effects that can increase the risk of bleeding. Therefore, this information is most important for the nurse to include in the teaching plan for this client, as the client should avoid taking these drugs while using ginkgo biloba or inform the healthcare provider if they are prescribed.
Choice D reason: Ginkgo biloba use should be limited and not taken during pregnancy, as there is insufficient evidence about its safety and efficacy for pregnant women. However, this information is not as important as choice c, as the client may not be pregnant or planning to become pregnant.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.